Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytokinetics, Inc.    CYTK

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CYTOKINETICS : Announces Phase I and Phase IIa Clinical Trial Results for Omecamtiv Mecarbil Published in the Journal Lancet

08/19/2011 | 08:40am US/Eastern
Results from These Trials Form the Basis For Ongoing Phase IIb Activities in Collaboration with Amgen

South San Francisco, CA - August 19, 2011

omecamtiv mecarbil, a novel cardiac myosin activator, in the August 20, 2011 issue of the journal Lancet. These two manuscripts present data regarding the safety, tolerability, pharmacokinetics and pharmacodynamic effects of this investigational drug candidate from a Phase I first-time-in-humans clinical trial in healthy volunteers and a Phase IIa clinical trial in stable heart failure patients, each sponsored by Cytokinetics. Together, these publications provide evidence for the translation into humans of this unique mechanistic approach to activating cardiac muscle contractility and support the further development of omecamtiv mecarbil as a potential treatment for heart failure. Amgen Inc. holds an exclusive, worldwide (excluding Japan) license to omecamtiv mecarbil and related compounds, subject to specified development and commercialization participation rights of Cytokinetics.

React to this article
Latest news on CYTOKINETICS, INC.
08/05 CYTOKINETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
07/30 CYTOKINETICS : Reports Second Quarter 2015 Financial Results
07/30 CYTOKINETICS : Reports Second Quarter 2015 Financial Results
07/29 CYTOKINETICS : reports 2Q loss
07/29 CYTOKINETICS : Results of Operations and Financial Condition, Financial Statemen..
07/29 Cytokinetics, Inc. Reports Second Quarter 2015 Financial Results
07/29 CYTOKINETICS : Reports Second Quarter 2015 Financial Results
07/22 CYTOKINETICS : And The ALS Association Announce Awarding Of Grant For Phase 3 Cl..
07/16 CYTOKINETICS : to Announce Second Quarter Results on July 29, 2015
07/15 Cytokinetics to Announce Second Quarter Results on July 29, 2015
Advertisement
Income Statement Evolution
More Financials